The study of Mycobacterium tuberculosis in Iranian patients with lung cancer

Jundishapur Journal of Microbiology

Volumn 6, Issue 3, 2013, Pages 237-241

  Asnaashari, Amir Mohamad Hashem ^a   Sadrizadeh, Ali ^a   Ahmadi, Hamid ^b   Meshkat, Mojtaba ^c   Gholoobi, Aida ^d   Talab, Fariba Rezai ^e   Aamini, Mahnaz ^e   Hosaini, Sayed Hosain Ahmadi ^e   Attaran, Davoud ^a   Tohidi, Mohammad ^a   Lari, Shahrzad Mohammadzadeh ^a   Basiri, Reza ^a   Nabavinia, Maryam Sadat ^d   Rostami, Sina ^f   Meshkat, Zahra ^d  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

Author keywords

Epidemiology; Lung Cancer; Mycobacterium tuberculosis

Indexed keywords

ADULT; ARTICLE; BACTERIUM CULTURE; CANCER PATIENT; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; IRAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MYCOBACTERIUM TUBERCULOSIS; PATIENT REFERRAL; PREVALENCE; TUBERCULOSIS CONTROL;

EID: 84877826217     PISSN: 20083645     EISSN: 20084161     Source Type: Journal    
DOI: 10.5812/jjm.4993     Document Type: Article

References (19)

1. Jemal Ahmedin, Bray Freddie, Center Melissa M, Ferlay Jacques, Ward Elizabeth, Forman David. Global cancer statistics. CA: A Cancer J clinicians. 2011;61(2):69-90
2. Siegel Rebecca, Ward Elizabeth, Brawley Otis, Jemal Ahmedin. Cancer statistics, 2011. CA: a cancer journal for clinicians. 2011;61(4):212-236
3. Hosseini M, Alinaghi SAS, Naghan PA, Karimi S, Bahadori M, Khodadad K, et al. A clinicopathologic study of lung cancer cases in Iran. Tanaffos. 2009;8(3):28-36
4. Sadjadi A, Nouraie M, Mohagheghi MA, Mousavi-Jarrahi A, Malekezadeh R, Parkin DM. Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev. 2005;6(3):359-63
5. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 1999;282(7):677-86
6. Salek S, Emami H, Masjedi MR, Velayati AA. Epidemiologic status of tuberculosis in Golestan province. Tanaffos. 2008;7(3):63-68
7. Nalbandian A, Yan BS, Pichugin A, Bronson RT, Kramnik I. Lung carcinogenesis induced by chronic tuberculosis infection: the experimental model and genetic control. Oncogene. Smith CJ, Perfetti TA, King JA. Perspectives on pulmonary inflammation and lung cancer risk in cigarette smokers. Inhal Toxicol. 2006;18(9):667-677
8. Ballaz S, Mulshine JL. The potential contributions of chronic inflammation to lung carcinogenesis. Clin Lung Cancer. 2003;5(1):46-62
9. Ramanakumar AV, Parent ME, Menzies D, Siemiatycki J. Risk of lung cancer following nonmalignant respiratory conditions: evidence from two case-control studies in Montreal, Canada. Lung Cancer. 2006;53(1):5-12
10. Kurasawa T, Takahashi M, Kuze F, Amitani R, Murayama T, Suzuki K, et al. A clinical study on coexistence of active pulmonary tuberculosis and lung cancer]. Kekkaku:[Tuberculosis]. 1992;67(2):119
11. Tamura A, Hebisawa A, Tanaka G, Tatsuta H, Tsuboi T, Nagai H, et al. Active pulmonary tuberculosis in patients with lung cancer]. Kekkaku:[Tuberculosis]. 1999;74(11):797
12. Wu CY, Hu HY, Pu CY, Huang N, Shen HC, Li CP, et al. Pulmonary tuberculosis increases the risk of lung cancer. Cancer. 2011;117(3):618-24
13. Yu YH, Liao CC, Hsu WH, Chen HJ, Liao WC, Muo CH, et al. Increased Lung Cancer Risk among Patients with Pulmonary Tuberculosis: A Population Cohort Study. J Thorac Oncol. 2011;6(1):32
14. Cicėnas S, Vencevičius V. Lung cancer in patients with tuberculosis. W J Surg Oncol. 2007;5(1):22
15. Engels EA, Shen M, Chapman RS, Pfeiffer RM, Yu YY, He X, et al. Tuberculosis and subsequent risk of lung cancer in Xuanwei, China. Int J Cancer. 2009;124(5):1183-1187
16. Wang C, Li X, Dai L, Zhang G, Gao L, Zhao Q, editors. Analysis of lung cancer gender differences and age structure in the high prevalence areas of Xiamen. 2011; IEEE
17. Schottenfeld D. Epidemiology of lung cancer. Lung cancer: principles and practice. 1996:305-321
18. Dalstra JAA, Kunst AE, Borrell C, Breeze E, Cambois E, Costa G, et al. Socioeconomic differences in the prevalence of common chronic diseases: an overview of eight European countries. Int J Epidemiol. 2005;34(2):316
19. Devesa SS, Diamond EL. Socioeconomic and racial differences in lung cancer incidence. American J Epidemiol. 1983;118(6):818